The adjusted operating expense ratio stood at 10.7%, an improvement of 60 basis points, reflecting our commitment to disciplined expense management and thoughtful prioritization of strategic investments.
Apr 22, 2025 / receipt, needs a key / Mark Kay, CFO | earnings call 2025-04-22 | transcript 31648ed3-b02c-42a5-8757-2aa7ce9be55c | chars 10776-10979 | segment 10
Elevant Health's adjusted operating expense ratio stood at 9.9% for the fourth quarter and 10.6% for the full year, an improvement of 170 basis points and 70 basis points, respectively, versus the prior year. This reflects our continued focus on disciplined expense management and operating efficiencies.
Jan 23, 2025 / receipt, needs a key / Mark Kay, CFO | earnings call 2025-01-23 | transcript 3cebaf70-9b1a-4e3c-aa9b-ca32b9b96e37 | chars 13640-13944 | segment 13
The adjusted operating expense ratio was 11.4%, consistent with the first quarter of 2023, indicative of our commitment to disciplined expense management and investment prioritization.
Apr 18, 2024 / receipt, needs a key / Mark Kay, CFO | earnings call 2024-04-18 | transcript c52ef864-54a5-4b6d-9c84-0692e3d5c39a | chars 12130-12314 | segment 12
Business optimization program charges
ir_statement / Sep 15, 2026 / receipt
Operating margin 3.5% 4.9% (140) bp
ir_statement / Sep 15, 2026 / receipt
Detecting cost trend earlier and with greater precision through clinical oversight, payment integrity, and faster execution
ir_statement / Sep 15, 2026 / receipt
Raising operating cash flow guidance to at least $6.0 billion
ir_statement / Sep 15, 2026 / receipt
Accelerating Targeted Investments to Strengthen Durable Operating Performance
ir_statement / Sep 15, 2026 / receipt
Expand CareBridge to new markets
ir_statement / Sep 15, 2026 / receipt
Raised 2026 Adjusted Diluted EPS Guidance To At Least $27.00
ir_statement / Sep 15, 2026 / receipt
raising 2026 guidance to at least $6.0 billion
ir_statement / Sep 15, 2026 / receipt
operating margin impacted by ongoing investment in the expansion of risk -based solutions
ir_statement / Sep 15, 2026 / receipt
Advance value -based care models to improve outcomes and reduce costs
ir_statement / Sep 15, 2026 / receipt
Driven by targeted membership growth, strategic geographic and product expansion, and growth in specialized populations
ir_statement / Sep 15, 2026 / receipt
Strengthen operational discipline to accelerate margin normalization
ir_statement / Sep 15, 2026 / receipt
| Felicia Norwood | President of government health benefits | - | receipt |
| Gail Boudreau | CEO | - | receipt |
| Gail Boudreaux | Chief Executive Officer | - | receipt |
| Joseph R. Swedish | President | - | receipt |
| Mark Kay | CFO | - | receipt |
| Melissa O' | CFO | - | receipt |
| Pete Haitayan | President of Carillon | - | receipt |
| Ronald W. Penczek | Chief Accounting Officer | - | receipt |
| 2017-11-06 | Chief Executive Officer, appointed | sec_8k |
| 2015-12-08 | Chief Accounting Officer, appointed | sec_8k |
| 2014-05-14 | President, appointed | sec_8k |
| 2014-02-21 | Executive Vice President, departed | sec_8k |